TOWER BRIDGE ADVISORS - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
TOWER BRIDGE ADVISORS ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2023$421,134
-20.4%
10,3830.0%0.03%
-22.7%
Q4 2022$529,222
-99.9%
10,3830.0%0.04%
-12.0%
Q3 2022$559,228,000
-18.8%
10,383
-3.1%
0.05%
-10.7%
Q2 2022$688,289,000
-17.2%
10,7160.0%0.06%0.0%
Q1 2022$830,919,000
-9.7%
10,7160.0%0.06%0.0%
Q4 2021$919,861,000
+6.7%
10,7160.0%0.06%
-1.8%
Q3 2021$861,888,000
-0.1%
10,7160.0%0.06%0.0%
Q2 2021$862,638,000
-4.6%
10,7160.0%0.06%
-16.2%
Q1 2021$903,787,000
-3.9%
10,716
-8.5%
0.07%
-11.7%
Q4 2020$940,092,000
+21.6%
11,716
+21.9%
0.08%
-2.5%
Q3 2020$772,997,000
-27.7%
9,612
-22.6%
0.08%
-34.2%
Q2 2020$1,068,845,000
+6.0%
12,4140.0%0.12%
-9.1%
Q1 2020$1,007,893,000
-2.1%
12,414
+0.8%
0.13%
+21.1%
Q4 2019$1,030,031,000
-1.5%
12,318
-7.5%
0.11%
-4.4%
Q3 2019$1,045,596,000
-4.1%
13,3180.0%0.11%
-6.6%
Q2 2019$1,090,744,000
-3.4%
13,318
-4.1%
0.12%
-6.9%
Q1 2019$1,129,315,000
+23.5%
13,8890.0%0.13%
+11.0%
Q4 2018$914,174,000
-17.5%
13,889
-3.4%
0.12%
+1.7%
Q3 2018$1,108,477,000
+4.4%
14,3790.0%0.12%
-1.7%
Q2 2018$1,061,745,000
+13.5%
14,3790.0%0.12%
+13.5%
Q1 2018$935,210,000
+0.6%
14,3790.0%0.10%
+4.0%
Q4 2017$929,459,000
+3.3%
14,379
+0.3%
0.10%
-2.0%
Q3 2017$899,961,000
+2.9%
14,342
-0.8%
0.10%
+2.0%
Q2 2017$874,924,000
+13.6%
14,452
-2.7%
0.10%
+11.1%
Q1 2017$770,225,000
+17.0%
14,8520.0%0.09%
+12.5%
Q4 2016$658,538,00014,8520.08%
Other shareholders
BAXTER INTL INC shareholders Q2 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders